ADA-话题@MedSci

#ADA#

386篇内容 | 2691人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1264743, encodeId=6b391264e43b2, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等, objectType=article, longId=193655, objectId=d3a919365588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a919365588, replyNumber=0, likeNumber=64, createdTime=2020-05-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a919365588, moduleTitle=中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a919365588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264742, encodeId=3add1264e4216, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=丹娜-法伯癌症研究所：新型靶向药物adavosertib治疗子宫癌具有惊人效果, objectType=article, longId=193074, objectId=ea421930e4e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea421930e4e5, replyNumber=0, likeNumber=77, createdTime=2020-04-29, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea421930e4e5, moduleTitle=丹娜-法伯癌症研究所：新型靶向药物adavosertib治疗子宫癌具有惊人效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea421930e4e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264741, encodeId=53691264e41bb, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=III期ADAURA试验：Tagrisso在EGFR突变型肺癌患者的辅助治疗中具有压倒性疗效, objectType=article, longId=192016, objectId=e03e1920168c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e03e1920168c, replyNumber=0, likeNumber=70, createdTime=2020-04-13, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e03e1920168c, moduleTitle=III期ADAURA试验：Tagrisso在EGFR突变型肺癌患者的辅助治疗中具有压倒性疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e03e1920168c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264740, encodeId=e1de1264e4026, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Blood：不同人种共有的ADAMTS13肽可结合不同的HLA-DR, objectType=article, longId=191698, objectId=9c9819169838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c9819169838, replyNumber=0, likeNumber=109, createdTime=2020-04-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c9819169838, moduleTitle=Blood：不同人种共有的ADAMTS13肽可结合不同的HLA-DR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c9819169838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264739, encodeId=e35e1264e39f7, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=安进联合Adaptive：开发针对新冠病毒的中和性抗体, objectType=article, longId=191369, objectId=eacd1913697a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eacd1913697a, replyNumber=0, likeNumber=78, createdTime=2020-04-05, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eacd1913697a, moduleTitle=安进联合Adaptive：开发针对新冠病毒的中和性抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eacd1913697a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264738, encodeId=b11d1264e3829, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Headache Pain：创伤后头痛的急性和预防性药物治疗：系统评价, objectType=article, longId=190028, objectId=de7d1900284e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de7d1900284e, replyNumber=0, likeNumber=54, createdTime=2020-03-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de7d1900284e, moduleTitle=J Headache Pain：创伤后头痛的急性和预防性药物治疗：系统评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de7d1900284e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264737, encodeId=94771264e37f6, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Headache：拉米替坦口服治疗偏头痛的急性发作后的疗效, objectType=article, longId=190027, objectId=a72519002ec1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a72519002ec1, replyNumber=0, likeNumber=67, createdTime=2020-03-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a72519002ec1, moduleTitle=Headache：拉米替坦口服治疗偏头痛的急性发作后的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a72519002ec1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264736, encodeId=48231264e3628, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Headache Pain：头痛了，选择舒马曲坦还是酮咯酸？, objectType=article, longId=190026, objectId=4dbe19002680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dbe19002680, replyNumber=0, likeNumber=81, createdTime=2020-03-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dbe19002680, moduleTitle=J Headache Pain：头痛了，选择舒马曲坦还是酮咯酸？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dbe19002680)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264735, encodeId=56cc1264e35cf, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Headache Pain：饮食也会影响偏头痛的发生, objectType=article, longId=190023, objectId=8ff419002328, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ff419002328, replyNumber=0, likeNumber=70, createdTime=2020-03-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ff419002328, moduleTitle=J Headache Pain：饮食也会影响偏头痛的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ff419002328)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264734, encodeId=1e1e1264e3460, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=强生的雄激素受体拮抗剂Erleada，获得欧洲药品管理局批准治疗去势敏感型前列腺癌, objectType=article, longId=187284, objectId=4eb418e284e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eb418e284e5, replyNumber=0, likeNumber=64, createdTime=2020-02-04, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eb418e284e5, moduleTitle=强生的雄激素受体拮抗剂Erleada，获得欧洲药品管理局批准治疗去势敏感型前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eb418e284e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264733, encodeId=aead1264e3328, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=重磅！2020 ADA糖尿病诊疗标准发布, objectType=article, longId=185636, objectId=7d1b185636b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d1b185636b6, replyNumber=0, likeNumber=65, createdTime=2020-01-05, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d1b185636b6, moduleTitle=重磅！2020 ADA糖尿病诊疗标准发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d1b185636b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264732, encodeId=8df21264e32ee, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2020 ADA 糖尿病医学诊疗标准, objectType=article, longId=185497, objectId=ac8918549ebc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac8918549ebc, replyNumber=0, likeNumber=28, createdTime=2020-01-01, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac8918549ebc, moduleTitle=2020 ADA 糖尿病医学诊疗标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac8918549ebc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264731, encodeId=062b1264e312c, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）, objectType=article, longId=185320, objectId=2df5185320cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2df5185320cd, replyNumber=0, likeNumber=25, createdTime=2019-12-28, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2df5185320cd, moduleTitle=2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2df5185320cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264730, encodeId=b43a1264e305f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=诺华的Adakveo获得FDA批准治疗镰状细胞性疼痛, objectType=article, longId=183194, objectId=5578183194d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5578183194d4, replyNumber=0, likeNumber=64, createdTime=2019-11-20, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5578183194d4, moduleTitle=诺华的Adakveo获得FDA批准治疗镰状细胞性疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5578183194d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264729, encodeId=44e11264e29dd, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2019 ADA临床实践指南：抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用, objectType=article, longId=183145, objectId=d3f0183145b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3f0183145b8, replyNumber=0, likeNumber=26, createdTime=2019-11-19, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3f0183145b8, moduleTitle=2019 ADA临床实践指南：抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3f0183145b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264728, encodeId=08751264e285b, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=浅谈基于效果反应的适应性随机化 (Response-Adaptive Randomization), objectType=article, longId=183035, objectId=4b911830358a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b911830358a, replyNumber=0, likeNumber=57, createdTime=2019-11-16, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b911830358a, moduleTitle=浅谈基于效果反应的适应性随机化 (Response-Adaptive Randomization), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b911830358a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264727, encodeId=24581264e27ef, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Lancet：Upadacitinib治疗强直性脊柱炎效果显著, objectType=article, longId=182959, objectId=eaac182959cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaac182959cb, replyNumber=0, likeNumber=60, createdTime=2019-11-15, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaac182959cb, moduleTitle=Lancet：Upadacitinib治疗强直性脊柱炎效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaac182959cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264726, encodeId=4eff1264e26ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=强生的雄激素受体抑制剂Erleada获得FDA批准，治疗转移性去势敏感性前列腺癌, objectType=article, longId=179672, objectId=33491e967221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33491e967221, replyNumber=0, likeNumber=76, createdTime=2019-09-20, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33491e967221, moduleTitle=强生的雄激素受体抑制剂Erleada获得FDA批准，治疗转移性去势敏感性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33491e967221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264725, encodeId=056c1264e25fe, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Adaptimmune和Noile-Immune宣布合作，开发增强型SPEAR T细胞肿瘤免疫疗法, objectType=article, longId=178294, objectId=d7c31e8294c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7c31e8294c4, replyNumber=0, likeNumber=63, createdTime=2019-08-30, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7c31e8294c4, moduleTitle=Adaptimmune和Noile-Immune宣布合作，开发增强型SPEAR T细胞肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7c31e8294c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264724, encodeId=ed3f1264e24da, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Am J Cardiol: ADAPT-DES研究：高血压合并氯吡格雷抵抗患者远期事件风险高, objectType=article, longId=178280, objectId=73931e828030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73931e828030, replyNumber=0, likeNumber=84, createdTime=2019-08-29, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73931e828030, moduleTitle=Am J Cardiol: ADAPT-DES研究：高血压合并氯吡格雷抵抗患者远期事件风险高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73931e828030)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADA

2020-05-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

中国NMPA授予Omadacycline优先审查：治疗社区获得性细菌性肺炎（CABP）等

2020-05-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

丹娜-法伯癌症研究所：新型靶向药物adavosertib治疗子宫癌具有惊人效果

2020-04-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

III期ADAURA试验：Tagrisso在EGFR突变型肺癌患者的辅助治疗中具有压倒性疗效

2020-04-13

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Blood：不同人种共有的ADAMTS13肽可结合不同的HLA-DR

2020-04-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

安进联合Adaptive：开发针对新冠病毒的中和性抗体

2020-04-05

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Headache Pain：创伤后头痛的急性和预防性药物治疗：系统评价

2020-03-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Headache：拉米替坦口服治疗偏头痛的急性发作后的疗效

2020-03-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Headache Pain：头痛了，选择舒马曲坦还是酮咯酸？

2020-03-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Headache Pain：饮食也会影响偏头痛的发生

2020-03-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

强生的雄激素受体拮抗剂Erleada，获得欧洲药品管理局批准治疗去势敏感型前列腺癌

2020-02-04

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

重磅！2020 ADA糖尿病诊疗标准发布

2020-01-05

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2020 ADA 糖尿病医学诊疗标准

2020-01-01

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2019 ADA/EASD共识：2型糖尿病患者高血糖的管理（更新版）

2019-12-28

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

诺华的Adakveo获得FDA批准治疗镰状细胞性疼痛

2019-11-20

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2019 ADA临床实践指南：抗生素在牙髓和根尖周相关牙痛以及口腔内肿胀紧急管理中的应用

2019-11-19

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

浅谈基于效果反应的适应性随机化 (Response-Adaptive Randomization)

2019-11-16

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Lancet：Upadacitinib治疗强直性脊柱炎效果显著

2019-11-15

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

强生的雄激素受体抑制剂Erleada获得FDA批准，治疗转移性去势敏感性前列腺癌

2019-09-20

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Adaptimmune和Noile-Immune宣布合作，开发增强型SPEAR T细胞肿瘤免疫疗法

2019-08-30

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Am J Cardiol: ADAPT-DES研究：高血压合并氯吡格雷抵抗患者远期事件风险高

2019-08-29

科室
- - 订阅+
  - 更多科室
工具
服务